{"entity":{"type":"insider","cik":"0001889967","url":"/insider/0001889967","json_url":"/insider/0001889967.json","name":"Morris Gabriel S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2021-12-20","last":"2025-12-10","span_basis":"filed_date"},"name_variants":[{"name":"Morris Gabriel S","source":"filing","n_filings":8,"first_seen":"2021-12-20","last_seen":"2025-12-10"}],"transactions":[{"id":4363592,"accession":"0001493152-25-027107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-027107","line_url":"/filing/0001493152-25-027107#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":770.0,"shares_display":"770","price_per_share":6.58,"price_display":"6.58","price_state":"stated","total_value":5066.6,"total_display":"5,066.60","total_whole":"5,067","shares_owned_after":291429.0,"shares_owned_after_display":"291,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-10","scope":"insider"},{"id":5168164,"accession":"0001493152-25-013918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-013918","line_url":"/filing/0001493152-25-013918#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2600.0,"shares_display":"2,600","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":5122.0,"total_display":"5,122.00","total_whole":"5,122","shares_owned_after":290659.0,"shares_owned_after_display":"290,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-17","scope":"insider"},{"id":4149333,"accession":"0001641172-25-015755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-015755","line_url":"/filing/0001641172-25-015755#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2225.0,"shares_display":"2,225","price_per_share":2.279,"price_display":"2.28","price_state":"stated","total_value":5070.775,"total_display":"5,070.78","total_whole":"5,071","shares_owned_after":288059.0,"shares_owned_after_display":"288,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":2400395,"accession":"0001493152-24-023288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-023288","line_url":"/filing/0001493152-24-023288#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.1192,"price_display":"2.12","price_state":"stated","total_value":5298.0,"total_display":"5,298.00","total_whole":"5,298","shares_owned_after":285834.0,"shares_owned_after_display":"285,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-10","scope":"insider"},{"id":2727061,"accession":"0001493152-24-022654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-022654","line_url":"/filing/0001493152-24-022654#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3300.0,"shares_display":"3,300","price_per_share":1.8099,"price_display":"1.81","price_state":"stated","total_value":5972.67,"total_display":"5,972.67","total_whole":"5,973","shares_owned_after":283334.0,"shares_owned_after_display":"283,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-05","scope":"insider"},{"id":3127622,"accession":"0001493152-24-019368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-019368","line_url":"/filing/0001493152-24-019368#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":2.2315,"price_display":"2.23","price_state":"stated","total_value":10041.75,"total_display":"10,041.75","total_whole":"10,042","shares_owned_after":85816.0,"shares_owned_after_display":"85,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-14","scope":"insider"},{"id":6861400,"accession":"0001493152-22-032555","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-032555","line_url":"/filing/0001493152-22-032555#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5200.0,"shares_display":"5,200","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":4888.0,"total_display":"4,888.00","total_whole":"4,888","shares_owned_after":81316.0,"shares_owned_after_display":"81,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-15","scope":"insider"},{"id":5522631,"accession":"0001493152-21-032035","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-21-032035","line_url":"/filing/0001493152-21-032035#line-4","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001889967","owner_name":"Morris Gabriel S","owner_display_name":"Morris Gabriel S","owner_url":"/insider/0001889967","role":"Director, Officer (Chief Financial Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":76116.0,"shares_owned_after_display":"76,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001873835","name":"Immix Biopharma, Inc.","url":"/issuer/0001873835","role":"Director, Officer (CFO)","n_filings":8,"first_seen":"2021-12-20","last_seen":"2025-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001889967","retrieved_at":"2026-08-25T01:55:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}